Pharmacology, Toxicology and Pharmaceutical Science
Anticarcinogen
11%
Biological Activity
11%
Breast Cancer
11%
Cancer Growth
100%
Carcinogenesis
11%
Cetuximab
11%
Clinical Trial
22%
Colon Carcinoma
11%
Epidermal Growth Factor Receptor
100%
Erlotinib
11%
Growth Factor Receptor
88%
Heme
22%
Malignant Neoplasm
44%
Neoplasm
44%
Ovary Cancer
11%
Progesterone
88%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
88%
Tumor Growth
22%
Biochemistry, Genetics and Molecular Biology
Anticancer
11%
Biological Activity
11%
Cancer Cell
22%
Carcinogenesis
11%
Cell Death
11%
Cell Growth
11%
Cell Membrane
11%
Cetuximab
11%
Clinical Trial
22%
Colon
11%
Drive
11%
Drug Sensitivity
11%
Epidermal Growth Factor Receptor
100%
Erlotinib
11%
Growth Factor Receptor
88%
Oxidation Reduction Reaction
11%
Progesterone
88%
Signal Transduction
11%
Small Molecule
100%
Tumor Progression
22%
Wild Type
11%